Rainer Kobelt

850 total citations
10 papers, 499 citations indexed

About

Rainer Kobelt is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Rainer Kobelt has authored 10 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Genetics and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Rainer Kobelt's work include Hemophilia Treatment and Research (6 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Rainer Kobelt is often cited by papers focused on Hemophilia Treatment and Research (6 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Rainer Kobelt collaborates with scholars based in Switzerland, Germany and Finland. Rainer Kobelt's co-authors include Rolf Ljung, W. Muntean, Chris Van Geet, Ana Rosa Cid, Anne Mäkipernaa, H. Marijke van den Berg, Gili Kenet, Carmen Escuriola, Elena Santagostino and Angela Thomas and has published in prestigious journals such as New England Journal of Medicine, Drugs and Archives of Disease in Childhood.

In The Last Decade

Rainer Kobelt

10 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rainer Kobelt Switzerland 6 417 110 84 48 27 10 499
Mayken Visser Germany 6 127 0.3× 129 1.2× 25 0.3× 91 1.9× 16 0.6× 11 234
Christiane Güthner Germany 5 71 0.2× 54 0.5× 23 0.3× 5 0.1× 25 0.9× 6 147
Katia Biasch France 8 41 0.1× 31 0.3× 73 0.9× 64 1.3× 21 0.8× 12 244
Roberto Malizia Italy 5 254 0.6× 276 2.5× 8 0.1× 26 0.5× 9 0.3× 5 306
C. Murphy Ireland 6 118 0.3× 137 1.2× 36 0.4× 6 0.1× 14 0.5× 11 208
Precious Pearl Landburg Netherlands 5 75 0.2× 108 1.0× 35 0.4× 13 0.3× 6 0.2× 8 149
Emöke Deschmann Sweden 6 96 0.2× 22 0.2× 15 0.2× 11 0.2× 5 0.2× 9 172
Janina Winogradow Germany 2 26 0.1× 27 0.2× 138 1.6× 207 4.3× 26 1.0× 2 266
Eva Rombout‐Sestrienkova Netherlands 9 232 0.6× 164 1.5× 14 0.2× 8 0.2× 8 0.3× 14 279
Paula James Canada 8 226 0.5× 52 0.5× 18 0.2× 22 0.5× 23 0.9× 19 253

Countries citing papers authored by Rainer Kobelt

Since Specialization
Citations

This map shows the geographic impact of Rainer Kobelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Kobelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Kobelt more than expected).

Fields of papers citing papers by Rainer Kobelt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Kobelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Kobelt. The network helps show where Rainer Kobelt may publish in the future.

Co-authorship network of co-authors of Rainer Kobelt

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Kobelt. A scholar is included among the top collaborators of Rainer Kobelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Kobelt. Rainer Kobelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Gouw, Samantha C., Johanna G. van der Bom, Rolf Ljung, et al.. (2013). Factor VIII Products and Inhibitor Development in Severe Hemophilia A. New England Journal of Medicine. 368(3). 231–239. 304 indexed citations
3.
Herbsleb, Marco, et al.. (2012). [Severe and moderate haemophilia under prophylactic replacement treatment--maximal knee extensor and flexor torque of children and adolescents].. PubMed. 32 Suppl 1. S62–9. 4 indexed citations
4.
Puta, Christian, et al.. (2012). Schwere und mittelschwere Hämophilie unter prophylaktischer Substitutions therapie. Hämostaseologie. 32(S 01). S62–S69. 3 indexed citations
5.
Morfini, Massimo, G. Auerswald, Rainer Kobelt, et al.. (2007). Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres. Haemophilia. 13(5). 502–507. 63 indexed citations
6.
Ljung, Rolf, Marijke van den Berg, Hérvè Chambost, et al.. (2000). Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries. Haemophilia. 6(6). 619–624. 58 indexed citations
7.
Greminger, P, et al.. (1994). Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Journal of Molecular Medicine. 72(11). 864–9. 38 indexed citations
8.
Schneider, Rebekka K., et al.. (1994). Pharmacokinetic Profile of Nifedipine GITS in Hypertensive Patients with Chronic Renal Impairment. Drugs. 48(Supplement 1). 16–22. 9 indexed citations
9.
Egger, Matthias, et al.. (1987). Twenty four hour intermittent, ambulatory blood pressure monitoring.. Archives of Disease in Childhood. 62(11). 1130–1135. 17 indexed citations
10.
Kobelt, Rainer & Schaad Ub. (1986). [Prospective evaluation of coagglutination and latex agglutination in the diagnosis of bacterial meningitis in childhood].. PubMed. 116(14). 431–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026